The Abbott Pandemic Defense Coalition: a unique multisector approach adds to global pandemic preparedness efforts
•Enhanced capacity for the detection of pandemic threats is needed globally.•Abbott launched the Abbott Pandemic Defense Coalition (APDC) in early 2021.•The APDC aims for the early detection of infectious disease threats of pandemic potential.•APDC has the novel capacity to rapidly develop and deplo...
Saved in:
Published in | International journal of infectious diseases Vol. 117; pp. 356 - 360 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Canada
Elsevier Ltd
01.04.2022
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | •Enhanced capacity for the detection of pandemic threats is needed globally.•Abbott launched the Abbott Pandemic Defense Coalition (APDC) in early 2021.•The APDC aims for the early detection of infectious disease threats of pandemic potential.•APDC has the novel capacity to rapidly develop and deploy diagnostics targeting new pathogens.
Detection and epidemiologic characterization of infectious disease outbreaks are key for early identification and response to potential pandemic threats. The rapid global spread of severe SARS-CoV-2 in 2020 highlighted the critical role of diagnostics in understanding the epidemiology of the virus early in the pandemic. As a natural extension of Abbott's work in diagnostics, virus discovery, and virus surveillance, the Abbott Pandemic Defense Coalition (APDC) was launched in early 2021. The APDC is a global multisector scientific and public health partnership whose primary objective is the early detection and mitigation of infectious disease threats of pandemic potential. As of January 2022, the APDC network has partners on 5 continents including academic institutions, governmental, and nongovernmental organizations. A novel element of the APDC is the capacity for early development and rapid deployment of scalable, quality diagnostics targeting newly identified pathogens of pandemic potential. |
---|---|
AbstractList | Detection and epidemiologic characterization of infectious disease outbreaks are key for early identification and response to potential pandemic threats. The rapid global spread of severe SARS-CoV-2 in 2020 highlighted the critical role of diagnostics in understanding the epidemiology of the virus early in the pandemic. As a natural extension of Abbott's work in diagnostics, virus discovery, and virus surveillance, the Abbott Pandemic Defense Coalition (APDC) was launched in early 2021. The APDC is a global multisector scientific and public health partnership whose primary objective is the early detection and mitigation of infectious disease threats of pandemic potential. As of January 2022, the APDC network has partners on 5 continents including academic institutions, governmental, and nongovernmental organizations. A novel element of the APDC is the capacity for early development and rapid deployment of scalable, quality diagnostics targeting newly identified pathogens of pandemic potential.Detection and epidemiologic characterization of infectious disease outbreaks are key for early identification and response to potential pandemic threats. The rapid global spread of severe SARS-CoV-2 in 2020 highlighted the critical role of diagnostics in understanding the epidemiology of the virus early in the pandemic. As a natural extension of Abbott's work in diagnostics, virus discovery, and virus surveillance, the Abbott Pandemic Defense Coalition (APDC) was launched in early 2021. The APDC is a global multisector scientific and public health partnership whose primary objective is the early detection and mitigation of infectious disease threats of pandemic potential. As of January 2022, the APDC network has partners on 5 continents including academic institutions, governmental, and nongovernmental organizations. A novel element of the APDC is the capacity for early development and rapid deployment of scalable, quality diagnostics targeting newly identified pathogens of pandemic potential. •Enhanced capacity for the detection of pandemic threats is needed globally.•Abbott launched the Abbott Pandemic Defense Coalition (APDC) in early 2021.•The APDC aims for the early detection of infectious disease threats of pandemic potential.•APDC has the novel capacity to rapidly develop and deploy diagnostics targeting new pathogens. Detection and epidemiologic characterization of infectious disease outbreaks are key for early identification and response to potential pandemic threats. The rapid global spread of severe SARS-CoV-2 in 2020 highlighted the critical role of diagnostics in understanding the epidemiology of the virus early in the pandemic. As a natural extension of Abbott's work in diagnostics, virus discovery, and virus surveillance, the Abbott Pandemic Defense Coalition (APDC) was launched in early 2021. The APDC is a global multisector scientific and public health partnership whose primary objective is the early detection and mitigation of infectious disease threats of pandemic potential. As of January 2022, the APDC network has partners on 5 continents including academic institutions, governmental, and nongovernmental organizations. A novel element of the APDC is the capacity for early development and rapid deployment of scalable, quality diagnostics targeting newly identified pathogens of pandemic potential. Detection and epidemiologic characterization of infectious disease outbreaks are key for early identification and response to potential pandemic threats. The rapid global spread of severe SARS-CoV-2 in 2020 highlighted the critical role of diagnostics in understanding the epidemiology of the virus early in the pandemic. As a natural extension of Abbott's work in diagnostics, virus discovery, and virus surveillance, the Abbott Pandemic Defense Coalition (APDC) was launched in early 2021. The APDC is a global multisector scientific and public health partnership whose primary objective is the early detection and mitigation of infectious disease threats of pandemic potential. As of January 2022, the APDC network has partners on 5 continents including academic institutions, governmental, and nongovernmental organizations. A novel element of the APDC is the capacity for early development and rapid deployment of scalable, quality diagnostics targeting newly identified pathogens of pandemic potential. |
Author | Berg, Michael Osmanov, Saladin Correa-Oliveira, Rodrigo Cloherty, Gavin Gamkrelidze, Amiran Meyer, Todd Suputtamongkol, Yupin Luo, Xinxin Alkashvili, Maia Hernandez, Juan Pablo Kaleebu, Pontiano Souleyman, Mboup Kallas, Esper G. Rodgers, Mary Landay, Alan Ciuoderis, Karl Deshommes, Johnson Osorio, Jorge Lindo, John de Olivera, Tulio Averhoff, Francisco Henry, Jean Hugues Manasa, Justen Anderson, Mark Solomon, Sunil Anzinger, Joshua |
Author_xml | – sequence: 1 givenname: Francisco surname: Averhoff fullname: Averhoff, Francisco email: francisco.averhoff@abbott.com organization: Abbott Diagnostics, Abbott Park, IL, USA – sequence: 2 givenname: Michael orcidid: 0000-0003-0233-5819 surname: Berg fullname: Berg, Michael email: michael.berg@abbott.com organization: Abbott Diagnostics, Abbott Park, IL, USA – sequence: 3 givenname: Mary surname: Rodgers fullname: Rodgers, Mary organization: Abbott Diagnostics, Abbott Park, IL, USA – sequence: 4 givenname: Saladin surname: Osmanov fullname: Osmanov, Saladin organization: Abbott Diagnostics (deceased), Abbott Park, IL, USA – sequence: 5 givenname: Xinxin surname: Luo fullname: Luo, Xinxin organization: Abbott Diagnostics, Abbott Park, IL, USA – sequence: 6 givenname: Mark surname: Anderson fullname: Anderson, Mark organization: Abbott Diagnostics, Abbott Park, IL, USA – sequence: 7 givenname: Todd surname: Meyer fullname: Meyer, Todd organization: Abbott Diagnostics, Abbott Park, IL, USA – sequence: 8 givenname: Alan surname: Landay fullname: Landay, Alan organization: Rush University Medical Center, Chicago, IL, USA – sequence: 9 givenname: Amiran surname: Gamkrelidze fullname: Gamkrelidze, Amiran organization: National Center for Disease Control, Tbilisi, Georgia – sequence: 10 givenname: Esper G. surname: Kallas fullname: Kallas, Esper G. organization: University of Sao Paulo, Sao Paulo, Brazil – sequence: 11 givenname: Karl surname: Ciuoderis fullname: Ciuoderis, Karl organization: Colombia Wisconsin One Health, University of Wisconsin & National University of Colombia, Medellin, Colombia – sequence: 12 givenname: Juan Pablo orcidid: 0000-0003-0404-9947 surname: Hernandez fullname: Hernandez, Juan Pablo organization: Colombia Wisconsin One Health, University of Wisconsin & National University of Colombia, Medellin, Colombia – sequence: 13 givenname: Jean Hugues surname: Henry fullname: Henry, Jean Hugues organization: Quisqueya University, Port-au-Prince, Haiti – sequence: 14 givenname: Jorge surname: Osorio fullname: Osorio, Jorge organization: Colombia Wisconsin One Health, University of Wisconsin & National University of Colombia, Medellin, Colombia – sequence: 15 givenname: John surname: Lindo fullname: Lindo, John organization: University of the West Indies, Kingston, Jamaica – sequence: 16 givenname: Johnson surname: Deshommes fullname: Deshommes, Johnson organization: Quisqueya University, Port-au-Prince, Haiti – sequence: 17 givenname: Joshua orcidid: 0000-0002-4541-4683 surname: Anzinger fullname: Anzinger, Joshua organization: University of the West Indies, Kingston, Jamaica – sequence: 18 givenname: Justen surname: Manasa fullname: Manasa, Justen organization: University of Zimbabwe, Harare, Zimbabwe – sequence: 19 givenname: Maia surname: Alkashvili fullname: Alkashvili, Maia organization: National Center for Disease Control, Tbilisi, Georgia – sequence: 20 givenname: Mboup surname: Souleyman fullname: Souleyman, Mboup organization: Institute for Health Research, Epidemiologic Surveillance and Training (IRESSEF), Dakar, Senegal – sequence: 21 givenname: Pontiano surname: Kaleebu fullname: Kaleebu, Pontiano organization: Uganda Virus Research Institute, Entebbe, Uganda – sequence: 22 givenname: Rodrigo surname: Correa-Oliveira fullname: Correa-Oliveira, Rodrigo organization: Foundation Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil – sequence: 23 givenname: Sunil surname: Solomon fullname: Solomon, Sunil organization: Johns Hopkins University School of Medicine, USA & YRG CARE, Chennai, India – sequence: 24 givenname: Tulio surname: de Olivera fullname: de Olivera, Tulio organization: Centre for Epidemic Response and Innovation, Stellenbosch University, Stellenbosch, South Africa – sequence: 25 givenname: Yupin surname: Suputtamongkol fullname: Suputtamongkol, Yupin organization: Mahidol University, Bangkok, Thailand – sequence: 26 givenname: Gavin surname: Cloherty fullname: Cloherty, Gavin organization: Abbott Diagnostics |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35134559$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUl1rHSEQXUpK89H-gT4UH_tyb9VdVw2lENKvQKB9SJ9l1p1NvPXqRr2B_Pt6e5PQ5CGFAcWZc2accw6bvRADNs1bRpeMsv7DaulWblxyyvmS1qDsRXPAlFSLVjC2V--csoWWjO83hzmvKKVd36tXzX7Nt50Q-qC5vrhCcjIMsRTyE8KIa2fJZ5wwZCSnEbwrLoZjAmQT3PUGyXrji8toS0wE5jlFsFcExjGTEsmljwN4Mt8TzQlnSDgGzJngNMVU8uvm5QQ-45u786j59fXLxen3xfmPb2enJ-cLKyQvC2EBLdXDJMapHykIGLQdLG21VF2vOYCeoP6Co5B9JxRqzhiqiWI_DrZr26PmbMc7RliZObk1pFsTwZm_DzFdGkjFWY9G9VJqYTnrJ9q1ArS2bctbVFIOyk62cn3acc2bYY2jxVAS-EekjzPBXZnLeGOUYrITshK8vyNIsW4xF7N22aL3EDBusuE9l6xte72d-92_vR6a3GtWC_iuwKaYc8LpoYRRszWGWZmtMczWGIbWoKyC1BOQdQW22tZ5nX8e-nEHxarWjcNksnUYLI4uVR_Udbrn4cdP4Na74Cz433j7P_Af4tno-w |
CitedBy_id | crossref_primary_10_3389_fmicb_2024_1362714 crossref_primary_10_3389_fmicb_2024_1419637 crossref_primary_10_3201_eid3010_240170 crossref_primary_10_3389_fpubh_2024_1323481 crossref_primary_10_1093_infdis_jiad406 crossref_primary_10_3201_eid2808_221006 crossref_primary_10_15446_dyna_v90n230_111828 crossref_primary_10_3389_feduc_2023_1241031 crossref_primary_10_1016_j_meegid_2024_105667 crossref_primary_10_3390_v15041022 |
Cites_doi | 10.1038/s41598-018-30078-5 10.1016/j.jviromet.2016.12.013 10.1016/j.ebiom.2021.103258 10.1016/j.virol.2017.01.008 10.1111/1468-0009.12186 10.7326/M17-0085 10.1128/JCM.00515-16 10.1016/j.ijid.2021.08.021 10.1097/QAI.0000000000002246 10.1371/journal.ppat.1005325 |
ContentType | Journal Article |
Copyright | 2022 The Author(s) Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved. 2022 The Author(s) 2022 |
Copyright_xml | – notice: 2022 The Author(s) – notice: Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved. – notice: 2022 The Author(s) 2022 |
DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
DOI | 10.1016/j.ijid.2022.02.001 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health |
EISSN | 1878-3511 |
EndPage | 360 |
ExternalDocumentID | oai_doaj_org_article_867795c216f0435a99c3323e877b8cfc PMC8817457 35134559 10_1016_j_ijid_2022_02_001 S1201971222000807 |
Genre | Journal Article |
GroupedDBID | --- --K .1- .FO .~1 0R~ 1B1 1P~ 1~. 1~5 29J 3O- 4.4 457 4G. 53G 5GY 5VS 7-5 71M 7X7 88E 8C1 8FI 8FJ 8FQ 8R4 8R5 AAEDW AAFWJ AAIKJ AALRI AAQFI AAQXK AARKO AAXUO AAYWO ABBQC ABFRF ABMAC ABUWG ABWVN ACGFO ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEFWE AEKER AENEX AEUPX AEVXI AEXQZ AFJKZ AFKRA AFPKN AFPUW AFRHN AFTJW AGEKW AGHFR AGQPQ AGYEJ AHMBA AIGII AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP ASPBG AVWKF AZFZN BAWUL BCNDV BENPR BPHCQ BR6 BVXVI CCPQU CS3 DIK DU5 DWQXO E3Z EBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FNPLU FYUFA G-Q GBLVA GROUPED_DOAJ GX1 HMCUK HVGLF HZ~ IHE IXB J1W KQ8 M1P M3C M3G M41 MO0 N9A O-L O9- OD- OK1 OO. OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO Q2X Q38 QTD R2- ROL RPZ RWL RXW SDF SDG SEL SES SEW SSZ TAE UKHRP UNMZH Z5R 0SF 3V. 6I. AACTN AAFTH ABVKL AFCTW NCXOZ RIG AAYXX ALIPV CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c572t-5caec09bf5df6d0a5ab9cbc039784692aa9fa1342e576458e9211e8f0e6dbc433 |
IEDL.DBID | DOA |
ISSN | 1201-9712 1878-3511 |
IngestDate | Wed Aug 27 01:32:54 EDT 2025 Thu Aug 21 18:16:12 EDT 2025 Thu Jul 10 22:27:29 EDT 2025 Tue Apr 29 09:42:36 EDT 2025 Thu Apr 24 23:11:32 EDT 2025 Tue Jul 01 04:30:10 EDT 2025 Fri Feb 23 02:38:45 EST 2024 Tue Aug 26 16:32:04 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | emerging pathogens, virus discovery, surveillance, public health Pandemic preparedness |
Language | English |
License | This is an open access article under the CC BY-NC-ND license. Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c572t-5caec09bf5df6d0a5ab9cbc039784692aa9fa1342e576458e9211e8f0e6dbc433 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 For the Abbott Pandemic Defense Coalition |
ORCID | 0000-0003-0404-9947 0000-0002-4541-4683 0000-0003-0233-5819 |
OpenAccessLink | https://doaj.org/article/867795c216f0435a99c3323e877b8cfc |
PMID | 35134559 |
PQID | 2627133693 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_867795c216f0435a99c3323e877b8cfc pubmedcentral_primary_oai_pubmedcentral_nih_gov_8817457 proquest_miscellaneous_2627133693 pubmed_primary_35134559 crossref_primary_10_1016_j_ijid_2022_02_001 crossref_citationtrail_10_1016_j_ijid_2022_02_001 elsevier_sciencedirect_doi_10_1016_j_ijid_2022_02_001 elsevier_clinicalkey_doi_10_1016_j_ijid_2022_02_001 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-04-01 |
PublicationDateYYYYMMDD | 2022-04-01 |
PublicationDate_xml | – month: 04 year: 2022 text: 2022-04-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Canada |
PublicationPlace_xml | – name: Canada |
PublicationTitle | International journal of infectious diseases |
PublicationTitleAlternate | Int J Infect Dis |
PublicationYear | 2022 |
Publisher | Elsevier Ltd The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases Elsevier |
Publisher_xml | – name: Elsevier Ltd – name: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases – name: Elsevier |
References | Martin, Fall (bib0013) 2021 Rodgers, Vallari, Harris, Yamaguchi, Holzmayer, Forberg, Berg, Kenmenge, Ngansop, Awazi, Mbanya, Kaptue, Brennan, Cloherty, Ndembi (bib0016) 2017; 504 Coller, Berg, Frankel, Forberg, Surani, Chiu, Hackett, Dawson (bib0009) 2016; 54 US Government Accountability Office, GAO. 2021. ‘Operation Warp Speed: Accelerated COVID-19 Vaccine Development Status and Efforts to Address Manufacturing Challenges’ Abbott Diagnostics, ADD. 2021a. Abbott Diagnostics, ADD. 2021b. Morens, Daszak, Markel, Taubenberger (bib0015) 2020 Rodgers, Olivo, Vallari, Harris, Lark, Luo, Berg, Meyer, Mohaimani, Orf, Goldstein, Fox, Hirschhorn, Glen, Nolte, Landay, Jennings, Moy, Servellita, Chiu, Batra, Snell, Nebbia, Douthwaite, Tanuri, Singh, Oliveira, Ahouidi, Mboup, Daghfal, Roth, Huang, Kovacs, Cloherty (bib0014) 2021 . Frankel, Forberg, Coller, Berg, Hackett, Cloherty, Dawson (bib0010) 2017; 241 Berg, Olivo, Harris, Rodgers, James, Mampunza, Niles, Baer, Yamaguchi, Kaptue, Laeyendecker, Quinn, McArthur, Cloherty (bib0007) 2021; 65 Berg, Lee, Coller, Frankel, Aronsohn, Cheng, Forberg, Marcinkus, Naccache, Dawson, Brennan, Jensen, Hackett, Chiu (bib0006) 2015; 11 Gostin, Katz (bib0011) 2016; 94 United Kingdom G7, UKG7. 2021. ‘100 Days Mission to respond to future pandemics: a report to the G7’ Abbott Laboratories, Abbott. 2020. Yamaguchi, Vallari, McArthur, Sthreshley, Cloherty, Berg, Rodgers (bib0019) 2020; 83 Abbott Laboratories, Abbott. 2021. Abid, Uddin, Muhammad, Awan, Applegate, Dore, Cloherty, Hamid (bib0005) 2021 Butler, Rodgers, Coller, Barnaby, Krilich, Olivo, Cassidy, Mbanya, Kaptue, Ndembi, Cloherty (bib0008) 2018; 8 Kandathil, Breitwieser, Sachithanandham, Robinson, Mehta, Timp, Salzberg, Thomas, Balagopal (bib0012) 2017; 167 Butler (10.1016/j.ijid.2022.02.001_bib0008) 2018; 8 Martin (10.1016/j.ijid.2022.02.001_bib0013) 2021 Berg (10.1016/j.ijid.2022.02.001_bib0006) 2015; 11 Kandathil (10.1016/j.ijid.2022.02.001_bib0012) 2017; 167 Rodgers (10.1016/j.ijid.2022.02.001_bib0014) 2021 Coller (10.1016/j.ijid.2022.02.001_bib0009) 2016; 54 Berg (10.1016/j.ijid.2022.02.001_bib0007) 2021; 65 10.1016/j.ijid.2022.02.001_bib0001 Gostin (10.1016/j.ijid.2022.02.001_bib0011) 2016; 94 10.1016/j.ijid.2022.02.001_bib0002 10.1016/j.ijid.2022.02.001_bib0003 10.1016/j.ijid.2022.02.001_bib0004 Frankel (10.1016/j.ijid.2022.02.001_bib0010) 2017; 241 Yamaguchi (10.1016/j.ijid.2022.02.001_bib0019) 2020; 83 Morens (10.1016/j.ijid.2022.02.001_bib0015) 2020 10.1016/j.ijid.2022.02.001_bib0017 Rodgers (10.1016/j.ijid.2022.02.001_bib0016) 2017; 504 10.1016/j.ijid.2022.02.001_bib0018 Abid (10.1016/j.ijid.2022.02.001_bib0005) 2021 |
References_xml | – reference: Abbott Diagnostics, ADD. 2021a. ‘ – volume: 54 start-page: 2023 year: 2016 end-page: 2030 ident: bib0009 article-title: Antibodies to the Novel Human Pegivirus 2 Are Associated with Active and Resolved Infections publication-title: J Clin Microbiol – volume: 8 start-page: 11617 year: 2018 ident: bib0008 article-title: High prevalence of hepatitis delta virus in Cameroon publication-title: Sci Rep – reference: Abbott Diagnostics, ADD. 2021b. ‘ – reference: . – start-page: 11 year: 2021 ident: bib0005 article-title: Evaluation of Hepatitis C Virus Core Antigen Assay in a Resource-Limited Setting in Pakistan publication-title: Diagnostics (Basel) – reference: ’. – reference: US Government Accountability Office, GAO. 2021. ‘Operation Warp Speed: Accelerated COVID-19 Vaccine Development Status and Efforts to Address Manufacturing Challenges’, – reference: United Kingdom G7, UKG7. 2021. ‘100 Days Mission to respond to future pandemics: a report to the G7’, – volume: 65 year: 2021 ident: bib0007 article-title: A high prevalence of potential HIV elite controllers identified over 30 years in Democratic Republic of Congo publication-title: EBioMedicine – reference: Abbott Laboratories, Abbott. 2020. ‘ – volume: 83 start-page: 319 year: 2020 end-page: 322 ident: bib0019 article-title: Brief Report: Complete Genome Sequence of CG-0018a-01 Establishes HIV-1 Subtype L’ publication-title: J Acquir Immune Defic Syndr – volume: 241 start-page: 34 year: 2017 end-page: 40 ident: bib0010 article-title: Development of a high-throughput multiplexed real time RT-PCR assay for detection of human pegivirus 1 and 2 publication-title: J Virol Methods – year: 2021 ident: bib0013 article-title: Field Epidemiology Training Programs to accelerate public health workforce development and global health security publication-title: Int J Infect Dis – volume: 504 start-page: 141 year: 2017 end-page: 151 ident: bib0016 article-title: Identification of rare HIV-1 Group N, HBV AE, and HTLV-3 strains in rural South Cameroon publication-title: Virology – volume: 94 start-page: 264 year: 2016 end-page: 313 ident: bib0011 article-title: The International Health Regulations: The Governing Framework for Global Health Security publication-title: Milbank Q – reference: Abbott Laboratories, Abbott. 2021. ‘ – volume: 11 year: 2015 ident: bib0006 article-title: Discovery of a Novel Human Pegivirus in Blood Associated with Hepatitis C Virus Co-Infection’ publication-title: PLoS Pathog – year: 2021 ident: bib0014 article-title: Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests publication-title: Journal of Clinical Virology (in review) – volume: 167 start-page: 1 year: 2017 end-page: 7 ident: bib0012 article-title: Presence of Human Hepegivirus-1 in a Cohort of People Who Inject Drugs publication-title: Ann Intern Med – start-page: 11 year: 2020 ident: bib0015 article-title: Pandemic COVID-19 Joins History’s Pandemic Legion publication-title: mBio – volume: 8 start-page: 11617 year: 2018 ident: 10.1016/j.ijid.2022.02.001_bib0008 article-title: High prevalence of hepatitis delta virus in Cameroon publication-title: Sci Rep doi: 10.1038/s41598-018-30078-5 – volume: 241 start-page: 34 year: 2017 ident: 10.1016/j.ijid.2022.02.001_bib0010 article-title: Development of a high-throughput multiplexed real time RT-PCR assay for detection of human pegivirus 1 and 2 publication-title: J Virol Methods doi: 10.1016/j.jviromet.2016.12.013 – volume: 65 year: 2021 ident: 10.1016/j.ijid.2022.02.001_bib0007 article-title: A high prevalence of potential HIV elite controllers identified over 30 years in Democratic Republic of Congo publication-title: EBioMedicine doi: 10.1016/j.ebiom.2021.103258 – ident: 10.1016/j.ijid.2022.02.001_bib0003 – start-page: 11 year: 2021 ident: 10.1016/j.ijid.2022.02.001_bib0005 article-title: Evaluation of Hepatitis C Virus Core Antigen Assay in a Resource-Limited Setting in Pakistan publication-title: Diagnostics (Basel) – ident: 10.1016/j.ijid.2022.02.001_bib0004 – start-page: 11 year: 2020 ident: 10.1016/j.ijid.2022.02.001_bib0015 article-title: Pandemic COVID-19 Joins History’s Pandemic Legion publication-title: mBio – volume: 504 start-page: 141 year: 2017 ident: 10.1016/j.ijid.2022.02.001_bib0016 article-title: Identification of rare HIV-1 Group N, HBV AE, and HTLV-3 strains in rural South Cameroon publication-title: Virology doi: 10.1016/j.virol.2017.01.008 – volume: 94 start-page: 264 year: 2016 ident: 10.1016/j.ijid.2022.02.001_bib0011 article-title: The International Health Regulations: The Governing Framework for Global Health Security publication-title: Milbank Q doi: 10.1111/1468-0009.12186 – ident: 10.1016/j.ijid.2022.02.001_bib0002 – volume: 167 start-page: 1 year: 2017 ident: 10.1016/j.ijid.2022.02.001_bib0012 article-title: Presence of Human Hepegivirus-1 in a Cohort of People Who Inject Drugs publication-title: Ann Intern Med doi: 10.7326/M17-0085 – ident: 10.1016/j.ijid.2022.02.001_bib0001 – ident: 10.1016/j.ijid.2022.02.001_bib0018 – volume: 54 start-page: 2023 year: 2016 ident: 10.1016/j.ijid.2022.02.001_bib0009 article-title: Antibodies to the Novel Human Pegivirus 2 Are Associated with Active and Resolved Infections publication-title: J Clin Microbiol doi: 10.1128/JCM.00515-16 – year: 2021 ident: 10.1016/j.ijid.2022.02.001_bib0013 article-title: Field Epidemiology Training Programs to accelerate public health workforce development and global health security publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2021.08.021 – volume: 83 start-page: 319 year: 2020 ident: 10.1016/j.ijid.2022.02.001_bib0019 article-title: Brief Report: Complete Genome Sequence of CG-0018a-01 Establishes HIV-1 Subtype L’ publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0000000000002246 – volume: 11 year: 2015 ident: 10.1016/j.ijid.2022.02.001_bib0006 article-title: Discovery of a Novel Human Pegivirus in Blood Associated with Hepatitis C Virus Co-Infection’ publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1005325 – ident: 10.1016/j.ijid.2022.02.001_bib0017 – year: 2021 ident: 10.1016/j.ijid.2022.02.001_bib0014 article-title: Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests publication-title: Journal of Clinical Virology (in review) |
SSID | ssj0004668 |
Score | 2.3861873 |
Snippet | •Enhanced capacity for the detection of pandemic threats is needed globally.•Abbott launched the Abbott Pandemic Defense Coalition (APDC) in early 2021.•The... Detection and epidemiologic characterization of infectious disease outbreaks are key for early identification and response to potential pandemic threats. The... |
SourceID | doaj pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 356 |
SubjectTerms | COVID-19 - epidemiology COVID-19 - prevention & control Disease Outbreaks emerging pathogens, virus discovery, surveillance, public health Humans Pandemic preparedness Pandemics - prevention & control Public Health SARS-CoV-2 |
SummonAdditionalLinks | – databaseName: Elsevier SD Freedom Collection dbid: .~1 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9QwFA7LPoggouttvBHBN6nT5tI2vq2jyyKsCLqwbyHJJNpF23Eur_52z0nSYauwgo9tk15yTs8l-c4XQl4y5oSMOD9VukJ4owojl7ZonS0tb0vH4-r52cf69Fx8uJAXB2Qx1sIgrDLb_mTTo7XOZ-Z5NOerrpt_rsB3qaYCBxfjHqwoF6JBLX_9q7pSG5nK4aBxga1z4UzCeHWXHbKFMpZ4O6uJc4oc_hMf9XcM-ieU8opvOrlDbuegkh6n975LDnx_RG6c5WXzI3IrTc7RVHN0j_wE5aDHcRcx-glnkX_AxXc-QErr6WLA0BzE9YYauov8rjTCDjdxgp-OLOQUbNaGbgeaOEXoarzRau0jrB2NKPUh4JrEfXJ-8v7L4rTIey8UTjZsW0hnvCuVDXIZ6mVppLHKWVdC-AIRi2LGqGAqLpiHhEXI1ivIJH0bSl8vrROcPyCH_dD7R4Q6CAOMDwYyPSdaBykxZN2CO9uwOnDDZ6QaB127TEyO-2N81yMC7VKjoDQKSpcMYXgz8mrfZ5VoOa5t_RZluW-JlNrxxLD-qrNOaST2U9Kxqg4lxJBGKcc5475tGtu64GaEj5qgx6pVsLNwo-7aR8t9r4le_7Pfi1HZNPzwuIpjej_sNprVDCcWagUD9zAp3_7DuASRQI44I81ELSdfPr3Sd98iqXjbQm4qm8f_-b5PyE08Spimp-Rwu975ZxCube3z-D_-BojKPZk priority: 102 providerName: Elsevier |
Title | The Abbott Pandemic Defense Coalition: a unique multisector approach adds to global pandemic preparedness efforts |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1201971222000807 https://dx.doi.org/10.1016/j.ijid.2022.02.001 https://www.ncbi.nlm.nih.gov/pubmed/35134559 https://www.proquest.com/docview/2627133693 https://pubmed.ncbi.nlm.nih.gov/PMC8817457 https://doaj.org/article/867795c216f0435a99c3323e877b8cfc |
Volume | 117 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELWgB4SEEJSvhVIZiRsKOHac2L31g6qAikCi0t4se9ZWt4Ls0t298tsZ20nUUKm9cMlhE2dlz8Qzz37zTMhbzqGSieenGRSVt7qwcuYKBY45oRiItHt--rU-Oas-T-X0ylFfkROW5YHzwH2IemtaAi_rwDC0W61BCC68ahqnIECcfTHm9WBqqIjMRXAY3grdlLwrl8nMrvnFPGqEcp7VOstRSErK_aPIdD3z_JdAeSUiHT8iD7tUku7nLjwmd3y7Te6ddpvl2-RBXpKjudLoCfmNLkH309lh9FtcO_6FN498QCDr6eEiJuRopD1q6SaputJENlylZX3aa49TnKlWdL2gWUmELvsXLS99IrPHqZP6EOJOxFNydvzxx-FJ0Z24UIBs-LqQYD0w7YKchXrGrLROgwOGSQvmKZpbq4MtRcU9wpRKKq8RP3oVmK9nDiohnpGtdtH6F4QCBn_rg0V8B5UCBMKItSsBruF1EFZMSNkPuoFOjjyeivHT9LyzCxMNZaKhDOORfDch74Y2yyzGcePTB9GWw5NRSDv9gO5lOvcyt7nXhIjeE0xfq4qzK75ofuNfy6FVl8nkDOXWdm96ZzP4mce9G9v6xWZleM3jckKtceCeZ-cbOiYkmgSR4YQ0I7cc9Xx8p52fJylxpRCRyubl_xiqV-R-7EqmNe2QrfXlxr_GjG3tdsnd93_K3fSJ4vXT9ACvX76rvznsP4A |
linkProvider | Directory of Open Access Journals |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwELZKkaASQlCu5TQSbyhsYsdJzFtZqBboVki0Ut8se9aGVCVZ9njltzO2k1UDUpF4jY_YnvEc9sxnQl4xBrkIcX4yhSS3WiZazE1SgUkNr1Lg4fZ8dlxMT_NPZ-Jsh0z6XBgfVtnJ_ijTg7Tuvoy71Rwv6nr8NUPdJcsMFVywe8pr5HqO29c_Y_DmV3YpOTLmw2HtxFfvMmdikFd9Xnu4UMYicGc20E4BxH-gpP42Qv-MpbyknA7vkNudVUkP4sDvkh3b7JMbs-7efJ_ciqdzNCYd3SM_kTvoQXhGjH7xx8g_sPC9dejTWjppvW2O9HpLNd0EgFca4g5X4YSf9jDkFIXWiq5bGkFF6KLvaLG0Ia7dS1FqnfOXEvfJ6eGHk8k06R5fSECUbJ0I0BZSaZyYu2KeaqGNBAMp2i9oskimtXQ64zmz6LHkorISXUlbudQWcwM55w_IbtM29hGhgHaAtk6jqwd5BegTo9udczAlKxzXfESyftEVdMjk_oGMC9WHoJ0rTyjlCaVS5uPwRuT1ts0i4nJcWfudp-W2psfUDh_a5TfVMZXyyH5SAMsKl6IRqaUEzhm3VVmaChyMCO85QfVpqyhosaP6yl-LbasBY_-z3cue2RTueH-NoxvbblaKFcyfLBQSF-5hZL7txLhAkqCTOCLlgC0HMx-WNPX3gCpeVeicivLxf473Bbk5PZkdqaOPx5-fkD1fEgOcnpLd9XJjn6HttjbPw978DWbJQLU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Abbott+Pandemic+Defense+Coalition%3A+a+unique+multisector+approach+adds+to+global+pandemic+preparedness+efforts&rft.jtitle=International+journal+of+infectious+diseases&rft.au=Averhoff%2C+Francisco&rft.au=Berg%2C+Michael&rft.au=Rodgers%2C+Mary&rft.au=Osmanov%2C+Saladin&rft.date=2022-04-01&rft.pub=Elsevier+Ltd&rft.issn=1201-9712&rft.volume=117&rft.spage=356&rft.epage=360&rft_id=info:doi/10.1016%2Fj.ijid.2022.02.001&rft.externalDocID=S1201971222000807 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1201-9712&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1201-9712&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1201-9712&client=summon |